Skip to main content
SpringerLink
Log in

Clinical Trials Report

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Song SH, Brown PM: Coronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications. Diabet Med 2004, 21:238–245.

    Article  PubMed  CAS  Google Scholar 

  2. Colagiuri S, Cull CA, Holman RR: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? UK Prospective Diabetes Study 61. Diabetes Care 2002, 25:1410–1417.

    Article  PubMed  Google Scholar 

  3. Saydah SH, Fradkin J, Cowie CC: Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004, 291:335–342.

    Article  PubMed  CAS  Google Scholar 

  4. Manley S: Haemoglobin A1c-a marker for complications of type 2 diabetes: the experience from the UK Prospective Diabetes Study (UKPDS). Clin Chem Lab Med 2003, 41:1182–1190.

    Article  PubMed  CAS  Google Scholar 

  5. Dahlof B, Devereux RB, Kjeldsen SE, et al.: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002, 359:995–1003.

    Article  PubMed  CAS  Google Scholar 

  6. Hansson L, Lindholm LH, Niskanen L, et al.: Effect of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomized trial. Lancet 1999, 353:611–616.

    Article  PubMed  CAS  Google Scholar 

  7. UK Prospective Diabetes Study Group: Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998, 317:713–720.

    Google Scholar 

  8. Hansson L, Lindholm LH, Ekbom T, et al.: Randomized trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity. The Swedish Trial in Old Patients with Hypertension-2 study. Lancet 1999, 354:1751–1756.

    Article  PubMed  CAS  Google Scholar 

  9. Dornhorst A, Powell SH, Pensky J: Aggravation by propranolol of hyperglycaemic effect of hydrochlorothiazide in type II diabetes without alteration of insulin secretion. Lancet 1985, 1:123–126.

    Article  PubMed  CAS  Google Scholar 

  10. Holzgreve H, Nakov R, Beck K, Janka HU: Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control. Am J Hypertens 2003, 16:381–386.

    Article  PubMed  CAS  Google Scholar 

  11. Chobanian AV, Bakris GL, Black HR, et al.: Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension 2003, 42:1206–1252.

    Article  PubMed  CAS  Google Scholar 

  12. Gaede P, Vedel P, Larsen N, et al.: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003, 348:383–393.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Kathleen H. Berecek PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David Calhoun MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berecek, K.H., Calhoun, D. Clinical Trials Report. Current Science Inc 7, 204–205 (2005). https://doi.org/10.1007/s11906-005-0011-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-005-0011-6

Keywords

Search

Navigation